gritt.io›Find investors›Biopharma in United States

Top 2026 Biopharma Investors in United States

Discover the top 286 biopharma investors in United States based on their portfolio. Get their email and LinkedIn info.

286
Investors
220
With email
77%
Email rate
Nov 2026
Last updated

Investor search results

286 investors found
🌍 United States🏷 Biopharma
Caroline Farah Lembck, MBA, PhD (abd)
Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
Late stage6 in Biopharma76 investments 📍 United States
6
in Biopharma
KL
Karen Liu
Healthcare Venture Investor
Late stage5 in Biopharma19 investments 📍 United States
5
in Biopharma
Richard Gaster, M.D., Ph.D.
Richard Gaster, M.D., Ph.D.
Managing Partner at venBio Partners
Mid stage5 in Biopharma18 investments 📍 United States
5
in Biopharma
Kiersten Stead
Kiersten Stead
Managing Partner DCVC Bio: Scientist-investor in early staged deep tech life sciences
Early stage3 in Biopharma23 investments 📍 United States
3
in Biopharma
Jake Nunn
Jake Nunn
Partner
Early stage3 in Biopharma10 investments 📍 United States
3
in Biopharma
Asish Xavier
Asish Xavier
Johnson & Johnson Innovation - JJDC
Mid stage3 in Biopharma14 investments 📍 United States
3
in Biopharma
Kulika Weizman
Kulika Weizman
Emerging Technologies Investor at Siemens
Early stage3 in Biopharma10 investments 📍 United States
3
in Biopharma
Colin Walsh, PhD
Colin Walsh, PhD
Managing Director - Life Sciences Investing at Goldman Sachs
Early stage3 in Biopharma12 investments 📍 United States
3
in Biopharma
Alan Walts
Alan Walts
Venture Partner at Advent Life Sciences
Early stage3 in Biopharma8 investments 📍 United States
3
in Biopharma
Kingsley Advani
Kingsley Advani
CEO of Allocations | Investor in 200+ companies
Early stage3 in Biopharma40 investments 📍 United States
3
in Biopharma

Frequently asked questions about Biopharma investors in United States

How many Biopharma investors are there in United States?
Gritt tracks 286 Biopharma investors in United States, of which 220 (77%) have a direct email address available.
How can I contact Biopharma investors in United States?
Gritt provides direct email addresses for 77% of investors in this list. On a paid plan you can unlock them and export the list, or use Gritt AI outreach to draft personalised emails that you approve, or let Gritt approve, and send from your Gmail.
Are these investors actively investing in United States startups?
Gritt lists them most active first, by the number of deals they have made in Biopharma, and each profile shows those deals and their dates. To see only investors who have invested recently, use the Last active filter.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Biopharma investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.

Contact all 286 Biopharma investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required